跳至主要内容
临床试验/CTRI/2025/11/097493
CTRI/2025/11/097493尚未招募不适用

Role of cerebroplacental ratio for perinatal outcomes in low-risk, early term pregnancy

Dr Aftab1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年11月25日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
150
试验地点
1
主要终点
FHR abnormality

研究概览

简要总结

All consecutive pregnant women  between 37 to 38+6 weeks with singleton live fetus will be evaluated by history taking  and examination as per the attached proforma.  The patients will be recruited according to the inclusion and exclusion criteria after obtaining their written consent regarding their willingness to be a part of the study.

Obstetrics ultrasound Doppler will be performed at the time of recruitment, including biometry, CPR, fetal weight and AFI to be measured. Patients will be categorized into SGA , AGA, and LGA. The pregnant women with AGA will be followed up till delivery. Intrapartum maternal and fetal monitoring will be done and the pregnancy outcomes will be recorded as follows :

Primary Outcomes – FHR abnormality

Secondary Outcomes – Meconium-stained liquor , Placental Abruption, Mode of delivery, Birth weight, APGAR, NICU admission (If yes- how many days), Need for Resuscitation, Occurrence of RDS, Perinatal mortality and morbidity, Gestational age at the time of delivery.

Role of cerebroplaental ratio for perinatal outcomes in low-risk, early term pregnancy will be analysed with statistical analysis.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 45.00 Year(s)(—)
性别
Female

入选标准

  • Low risk primigravida with singleton live pregnancy between 37wks to 38+6weeks POG with appropriate for gestational age fetus.

排除标准

  • Fetal anomalies Maternal complications (e.g. hypertension in pregnancy , hyprerglycemia in pregnancy , Polyhydramnios , Oligohydramnios ,Anemia etc) History of chronic diseases like chronic liver disease, chronic respiratory disease, chronic renal disease etc.

结局指标

主要结局

FHR abnormality

时间窗: During Labour

次要结局

  • GESTATIONAL AGE AT THE TIME OF DELIVERY(MECONIUM STAINED LIQUOR)

研究者

发起方
Dr Aftab
申办方类型
Other [Dr Aftab ]
责任方
Principal Investigator
主要研究者

Mohd Aftab

Dr RML Hospital

研究点 (1)

Loading locations...

相似试验